pharmaboardroom.com
Open in
urlscan Pro
35.189.116.82
Public Scan
Submitted URL: http://pharmaboardroom.com/
Effective URL: https://pharmaboardroom.com/
Submission: On February 11 via manual from HK — Scanned from GB
Effective URL: https://pharmaboardroom.com/
Submission: On February 11 via manual from HK — Scanned from GB
Form analysis 2 forms found in the DOM
GET https://pharmaboardroom.com/
<form id="header_search_form" action="https://pharmaboardroom.com/" role="search" method="get" class="form-inline my-2 my-lg-0 search-form">
<div class="center-search d-flex align-items-center justify-content-center bd-highlight mb-3">
<span class="screen-reader-text">Search for:</span>
<input class="form-control mr-sm-2 search-form__input" id="search-bar" type="search" data-swplive="true" title="Search for:" value="" name="s"
aria-label="When autocomplete results are available use up and down arrows to review and enter to go to the desired page. Touch device users, explore by touch or with swipe gestures." placeholder="Search" autocomplete="off"
aria-owns="searchwp_live_search_results_63e7a9cfc50ba" aria-autocomplete="both">
<button class="btn nav-btn search-form__submit">
<i class="fa fa-search"></i>
</button>
</div>
</form>POST login
<form action="login" method="post">
<fieldset>
<label for="username" class="sr-only">Username</label>
<input id="username" type="text" name="username" placeholder="Username">
<label for="password" class="sr-only">Password</label>
<input id="password" type="password" name="password" placeholder="Password">
<button class="btnc btnc--pill salmon large follow-off" name="submit">Sign in </button>
<p class="status"></p>
<div>
<a href="https://pharmaboardroom.com/login?action=forgot_password" class="lost mp-text-link">Forgot password?</a>
</div>
<div>
<a href="https://pharmaboardroom.com/register/member/" class="lost mp-text-link">No Account? Register Now.</a>
</div>
</fieldset>
<input type="hidden" id="security" name="security" value="1d057de6ce"><input type="hidden" name="_wp_http_referer" value="/"> <input type="hidden" id="redirect-after-login" value="https://pharmaboardroom.com/">
</form>Text Content
WE VALUE YOUR PRIVACY We and our partners store and/or access information on a device, such as cookies and process personal data, such as unique identifiers and standard information sent by a device for personalised ads and content, ad and content measurement, and audience insights, as well as to develop and improve products.With your permission we and our partners may use precise geolocation data and identification through device scanning. You may click to consent to our and our partners’ processing as described above. Alternatively you may access more detailed information and change your preferences before consenting or to refuse consenting.Please note that some processing of your personal data may not require your consent, but you have a right to object to such processing. Your preferences will apply to this website only. You can change your preferences at any time by returning to this site or visit our privacy policy. MORE OPTIONS AGREE Search for: * Sign in * Register * Country Reports * Interviews * InFocus * Europe * Asia-Pacific * Americas * Middle East & Africa * Legal & Regulatory * Facts & Figures * Library * Op-eds * Shop Sign In Register * Home * Country Reports * All * Americas * Asia-Pacific * Europe * Middle East & Africa * Exclusive interviews * All * Latest * Americas * Asia-Pacific * Europe * Middle East & Africa * Articles * All * Global * Latest * Legal & Regulatory * All * The Pharma Legal Handbook * Regulatory, Pricing and Reimbursement * Marketing, Manufacturing, Packaging and Labeling * Preclinical and Clinical Trials * Op-Eds & Contributions * InFigures * All * Rankings * Americas * Asia-Pacific * Europe * Middle East & Africa * Library * All * InFocus * InFigures * White Papers * Media Kit * Register * About Us * Country Reports * Interviews * InFocus * Europe * Asia-Pacific * Americas * Middle East & Africa * Legal & Regulatory * Facts & Figures * Library * Op-eds * Shop TOP STORIES CHINA / PHARMA MARKET GROWTH 2016-2025 The Chinese pharma market grew by eight percent from 2016 to 2018, slowed to four percent between 2018 and 2022 in part thanks to the introduction of volume-based procurement (VBP), and looks set to return to a healthier seven percent… Save Share LEADERSHIP / ASTELLAS TO "GO ON THE AGGRESSIVE" UNDER NEW CEO In the five years since the Japanese drugmaker began a strategic shift and created an ambitious plan to maintain growth, CEO Kenji Yasukawa helped Astellas move away from its previous… Save Share DENMARK / ETHICS AUTHORITY HEAD TALKS ETHICS BY DESIGN IN MEDICAL RESEARCH Denmark has long been a global frontrunner in medical research ethics and now boasts a more robust ethical infrastructure, spearheaded by a new body, The National Centre for Ethics. Head… Save Share THE LONG READ / EGYPT: DELIVERING THE DREAM Barely four and a half years ago, Egyptian President Abdel Fattah el-Sisi secured overwhelming re-election vowing to “place public health front and centre” of a radical reform and stabilization agenda.… Save Share GREECE / THE RISK TAKER SPEARHEADING A NATIONAL PHARMA MANUFACTURING PUSH DEMO, founded in 1965, is a mainstay of Greek pharma and one of its largest companies, accounting for 25 percent of the total investment across the entire Greek pharmaceutical sector.… Save Share CEE / POLPHARMA'S ZENTIVA BID; GEDEON RICHTER ACQUISITION & FDA APPROVAL; NEW PHARMA TAX IN HUNGARY Some of the most important stories emanating from the Central and Eastern European (CEE) region’s pharma industry, including Polpharma’s bid for Zentiva, Richter’s acquisition of OC Distributors and MDD approval… Save Share VACCINES / SK BIOSCIENCE ADVANCES POST-COVID STRATEGY WITH FIRST LATAM FLU APPROVAL Korean biotech SK Bioscience, known for bringing forward the first South Korean-developed COVID-19 vaccine, is pursuing its beyond-COVID growth strategy with a new green light for its SKYCellflu vaccine. The… Save Share See more... IN CONVERSATION GEORGE CARYSTINOS – GENERAL MANAGER GREECE, CYPRUS & ISRAEL, IPSEN Ipsen’s George Carystinos explains what brought him back to Greece for a first country manager position after a succession of global roles, how the company’s global specialty care transformation is playing out in the Greek market, and why he is optimistic about the impact that Ipsen’s portfolio can have in the country. A third point of attraction was the… Save Share NAVIN PINTO – ATTENDING PHYSICIAN, SEATTLE… Paediatric oncologist Navin Pinto, MD outlines the current use and potential of CAR-T therapies in his field, including the manufacturing… Save Share MARIA GABRIELA PITTIS – HEAD OF SOUTH CONE, ANDEAN… Maria Gabriela Pittis, Head of SAM (South Cone, Andean Region, Mexico & Central America and Caribbean) at Takeda, outlines the… Save Share See more... FOCUS ON AMERICAS SK BIOSCIENCE ADVANCES POST-COVID STRATEGY WITH FIRST LATAM… Korean biotech SK Bioscience, known for bringing forward the first South Korean-developed COVID-19 vaccine, is pursuing its beyond-COVID growth strategy with a new green light for its SKYCellflu vaccine. The… Save Share MARKET ACCESS IN LATAM: INSIGHTS FROM THE TOP While regulatory agencies in several Latin American countries have made significant efforts to improve processes and accelerate approval times, a number of access hurdles still remain across the region. Here,… Save Share TAKEDA DENGUE VACCINE’S EU GO-AHEAD SETS THE STAGE FOR… After gaining its first global approval in Indonesia, Takeda’s dengue fever vaccine, Qdenga, recently got a green light from the European Commission (EC) to market the vaccine in Europe, laying… Save Share MEXICO: SANFER LOOKING TO BUILD ON LATAM FOOTPRINT WITH… Mexico, with the second largest pharmaceutical market in Latin America, has a number of strong local pharma industry players. These companies, no longer focused solely on the domestic market, are… Save Share READ MORE: AMERICAS >> FOCUS ON EUROPE THE NEW EU HEALTH TECHNOLOGY ASSESSMENT REGULATION: BUILDING… Edward Mc Gettrick and Sharon Gorman of Pfizer, writing in the January 2023 edition of DIA’s Global Forum magazine, examine the scope and impact of the European Union's new Regulation on… Save Share FRANCE PHARMA ROUNDUP: MEDICINE SHORTAGES; CARMAT’S… The latest news from French pharma, including fears of medicine shortages and suspension of online sales of paracetamol, CARMAT's artificial heart product entering a study in France, Sanofi's expanded deal… Save Share DEMO PHARMA: THE RISK TAKER SPEARHEADING GREECE’S… DEMO, founded in 1965, is a mainstay of Greek pharma and one of its largest companies, accounting for 25 percent of the total investment across the entire Greek pharmaceutical sector.… Save Share CEE PHARMA NEWS: POLPHARMA ZENTIVA BID; RICHTER ACQUISITION… Some of the most important stories emanating from the Central and Eastern European (CEE) region’s pharma industry, including Polpharma's bid for Zentiva, Richter's acquisition of OC Distributors and MDD approval… Save Share READ MORE: EUROPE >> FOCUS ON ASIA TAIWAN BIOTECH NEWS: GONGWIN-KY’S LUNG CANCER… The latest pharma news from Taiwan, including Gongwin-KY's lung cancer drug approval in China, Anxo Pharmaceutical/Genovior Biotech alliance, Taiwan's Industrial Technology Research Institute (ITRI) and Metagone Biotech's glaucoma and macular… Save Share VIETNAM PHARMA AND HEALTHCARE NEWS: GILEAD’S VIRAL… A roundup of recent pharma and healthcare news from Vietnam including Gilead's viral hepatitis initiative, the country's explosion of dengue fever cases and the investigation into Boston Scientific's Vietnam operations.… Save Share EVOLVING COMPASSIONATE USE AND NAMED PATIENT PROGRAMS ACROSS… Through compassionate use programs patients suffering from critical, life-threatening conditions can access potential life-saving therapeutic options which have not been formally approved by the responsible health authority in an ethical… Save Share FIRST APPROVAL FOR TAKEDA DENGUE VACCINE Takeda gets a first approval for QDENGA, its dengue vaccine, which has been given the green light by the Indonesian National Agency for Drug and Food Control, Badan Pengawas Obat… Save Share READ MORE: ASIA >> FOCUS ON MENA LEADING THE WAY IN MENA FOR BIOLOGICALS & BIOSIMILARS… The leading company in the Egyptian pharma market by volume, the Egyptian International Pharmaceutical Industries Company (EIPICO) is now making a region-first move into biologicals and biosimilars manufacturing to power… Save Share SAUDI ARABIA HEALTHCARE & PHARMA NEWS: CINFA EXPANDS… Some of the most significant stories coming out of Saudi Arabia’s dynamic pharmaceutical industry, including Spanish firm Cinfa’s decision to reinforce its presence in the country, how Saudi and other… Save Share SIX EGYPT PHARMA MARKET TRENDS TO WATCH As Egypt moves towards universal healthcare coverage for its 100 million-plus population, the country has become the fastest growing pharma market in the Middle East and Africa region with a… Save Share EGYPT: ‘A KEY OPPORTUNITY’ FOR MEA GENERAL MANAGERS As the largest pharma market in MEA in terms of volume and second only behind Saudi in value, Egypt is an increasingly important part of pharma multinationals’ MEA operations. Here,… Save Share READ MORE: MENA >> We use cookies to ensure that we give you the best experience on our site. For more info See our Cookie Privacy Policy Here Accept PHARMABOARDROOM * About us * Media Kit LEGAL & PRIVACY * Terms and Conditions * Privacy and Cookies policy CONTACT US +44 2078673717 info@pharmaboardroom.com For media inquiries, please contact: media@pharmaboardroom.com Address: PharmaBoardroom Limited Evolution House Iceni Court, Delft Way, Norwich, NR6 6BB UK SUBSCRIBE Email Newsletters SOCIAL MEDIA × SIGN IN Username Password Sign in Forgot password? No Account? Register Now.